This HND piece puts the spotlight on Ibogaine, a hallucinogenic drug with demonstrated anti-addictive properties. Not surprisingly, these properties were discovered inadvertently by a heroin addict, as he and a group of friends were experimenting with other drugs.
They were astonished to find that they lost their cravings for heroin, and had no withdrawal symptoms, either.
However, being classified as a Schedule I drug, ibogaine is stigmatized, and even if it weren't, ti is a naturally-occurring substance, so there is no inherent interest by Big Pharma. Fortunately, there is plenty of positive literature on the matter, and the powers-that-be are finally taking an interest.
Read the complete article.